BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9721974)

  • 1. Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis.
    Inthorn D; Hoffmann JN; Hartl WH; Mühlbayer D; Jochum M
    Shock; 1998 Aug; 10(2):90-6. PubMed ID: 9721974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction.
    Inthorn D; Hoffmann JN; Hartl WH; Mühlbayer D; Jochum M
    Shock; 1997 Nov; 8(5):328-34. PubMed ID: 9361342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The circulating adhesion molecules sICAM-1 and sP-selectin in patients with sepsis].
    Egerer K; Rohr U; Krausch D; Kox W
    Anaesthesist; 1997 Jul; 46(7):592-8. PubMed ID: 9304360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure.
    Whalen MJ; Doughty LA; Carlos TM; Wisniewski SR; Kochanek PM; Carcillo JA
    Crit Care Med; 2000 Jul; 28(7):2600-7. PubMed ID: 10921602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of antithrombin III activity after supplementation decreases in proportion to the severity of sepsis and liver dysfunction.
    Hayakawa M; Sawamura A; Yanagida Y; Sugano M; Hoshino H; Gando S
    Shock; 2008 Dec; 30(6):649-52. PubMed ID: 18496242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection.
    Kayal S; Jaïs JP; Aguini N; Chaudière J; Labrousse J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):776-84. PubMed ID: 9517590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of antithrombin isoform proportions in plasma samples of healthy subjects, sepsis patients, and in antithrombin concentrates.
    Römisch J; Dönges R; Stauss H; Inthorn D; Mühlbayer D; Jochum M; Hoffmann J
    Pathophysiol Haemost Thromb; 2002; 32(3):143-50. PubMed ID: 12372930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study.
    Cowley HC; Heney D; Gearing AJ; Hemingway I; Webster NR
    Crit Care Med; 1994 Apr; 22(4):651-7. PubMed ID: 7511496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of antithrombin III and serum C-reactive protein concentration in critically ill patients with suspected sepsis.
    Pettilä V; Pentti J; Pettilä M; Takkunen O; Jousela I
    Crit Care Med; 2002 Feb; 30(2):271-5. PubMed ID: 11889291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple advice on lifestyle habits and long-term changes in biomarkers of inflammation and vascular adhesion in healthy middle-aged men.
    Sjögren P; Cederholm T; Heimbürger M; Stenvinkel P; Vedin I; Palmblad J; Hellenius ML
    Eur J Clin Nutr; 2010 Dec; 64(12):1450-6. PubMed ID: 20859301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure.
    Endo S; Inada K; Kasai T; Takakuwa T; Yamada Y; Koike S; Wakabayashi G; Niimi M; Taniguchi S; Yoshida M
    J Inflamm; 1995-1996; 46(4):212-9. PubMed ID: 8878795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
    Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass.
    Tárnok A; Hambsch J; Emmrich F; Sack U; van Son J; Bellinghausen W; Borte M; Schneider P
    Pediatr Cardiol; 1999; 20(2):113-25. PubMed ID: 9986887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.
    Warren BL; Eid A; Singer P; Pillay SS; Carl P; Novak I; Chalupa P; Atherstone A; Pénzes I; Kübler A; Knaub S; Keinecke HO; Heinrichs H; Schindel F; Juers M; Bone RC; Opal SM;
    JAMA; 2001 Oct; 286(15):1869-78. PubMed ID: 11597289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttraumatic immune modulation in chronic alcoholics is associated with multiple organ dysfunction syndrome.
    von Heymann C; Langenkamp J; Dubisz N; von Dossow V; Schaffartzik W; Kern H; Kox WJ; Spies C
    J Trauma; 2002 Jan; 52(1):95-103. PubMed ID: 11791058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules.
    Døllner H; Vatten L; Austgulen R
    J Clin Epidemiol; 2001 Dec; 54(12):1251-7. PubMed ID: 11750194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jack A. Barney Resident Research Award winner. The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure.
    Partrick DA; Moore FA; Moore EE; Biffl WL; Sauaia A; Barnett CC
    Am J Surg; 1996 Nov; 172(5):425-9; discussed 429-31. PubMed ID: 8942538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure.
    Bellomo R; Tipping P; Boyce N
    Ren Fail; 1995 Jul; 17(4):457-66. PubMed ID: 7569116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis.
    Hoffmann JN; Mühlbayer D; Jochum M; Inthorn D
    Crit Care Med; 2004 Sep; 32(9):1851-9. PubMed ID: 15343012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia.
    Ishikawa K; Tanaka H; Matsuoka T; Shimazu T; Yoshioka T; Sugimoto H
    J Trauma; 1998 Jun; 44(6):1047-54; discussion 1054-5. PubMed ID: 9637161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.